Altimmune Inc. research and ratings by Barron's. View ALT revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.

Altimmune, a clinical-stage biopharmaceutical company from Maryland developing innovative next-generation peptide-based therapeutics, welcomed two industry veterans to its Board of Directors.